Our laboratory is committed to the construction of cancer-specific oHSVs retargeted to cancer-specific receptors of choice, and detargeted from the natural receptors Nectin1 and HVEM [14,15,16,17,18,19,20,21,22,23,24,25]. This evidence concerns the gene TNFRSF14 and cancer.